Company Registration No. 4567617 (England and Wales)
Cochrane Opportunity Enterprises Limited
Unaudited accounts
for the year ended 31 March 2022
Cochrane Opportunity Enterprises Limited
Unaudited accounts
Contents
Cochrane Opportunity Enterprises Limited
Company Information
for the year ended 31 March 2022
Director
Lyndsay Margaret Cochrane
Company Number
4567617 (England and Wales)
Registered Office
5 Commercial Street
Ystradgynlais
Swansea
SA9 1HD
United Kingdom
Cochrane Opportunity Enterprises Limited
Statement of financial position
as at 31 March 2022
Tangible assets
685,172
492,428
Cash at bank and in hand
470,774
647,566
Creditors: amounts falling due within one year
(25,608)
(52,246)
Net current assets
848,565
938,122
Net assets
1,533,737
1,430,552
Called up share capital
2
2
Profit and loss account
1,533,735
1,430,550
Shareholders' funds
1,533,737
1,430,552
For the year ending 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 9 June 2022 and were signed on its behalf by
Lyndsay Margaret Cochrane
Director
Company Registration No. 4567617
Cochrane Opportunity Enterprises Limited
Notes to the Accounts
for the year ended 31 March 2022
Cochrane Opportunity Enterprises Limited is a private company, limited by shares, registered in England and Wales, registration number 4567617. The registered office is 5 Commercial Street, Ystradgynlais, Swansea, SA9 1HD, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% per annum
4
Tangible fixed assets
Land & buildings
Fixtures & fittings
Total
Cost or valuation
At cost
At cost
At 1 April 2021
469,131
100,869
570,000
Additions
351,900
-
351,900
Disposals
(153,332)
-
(153,332)
At 31 March 2022
667,699
100,869
768,568
At 1 April 2021
-
77,572
77,572
Charge for the year
-
5,824
5,824
At 31 March 2022
-
83,396
83,396
At 31 March 2022
667,699
17,473
685,172
At 31 March 2021
469,131
23,297
492,428
Cochrane Opportunity Enterprises Limited
Notes to the Accounts
for the year ended 31 March 2022
5
Investments
Subsidiary undertakings
Valuation at 1 April 2021
2
Valuation at 31 March 2022
-
Amounts falling due within one year
Amounts falling due after more than one year
Other debtors
347,755
342,802
7
Creditors: amounts falling due within one year
2022
2021
Taxes and social security
5,101
1,123
Other creditors
2,000
2,500
Loans from directors
18,507
48,623
8
Average number of employees
During the year the average number of employees was 0 (2021: 0).
